Migraine patients dissatisfied with treatment in Europe, US

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.313, 2001-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Practical Considerations for the Treatment of Elderly Patients with Migraine

By Sarchielli Paola   Maria Luisa Mancini   Calabresi Paolo  

Drugs & Aging, Vol. 23, Iss. 6, 2006-01 ,pp. : 461-489

Adis International

Access to resources Recommend Favorite

Dihydroergotamine: role in the treatment of migraine

By Schürks Markus  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 9, 2009-09 ,pp. : 1141-1148

Informa Healthcare

Access to resources Recommend Favorite

Treatment of migraine with prophylactic drugs

By Evers Stefan  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2565-2573

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs in migraine treatment

By Waeber Christian  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 437-456

Informa Healthcare

Access to resources Recommend Favorite

Prevention and Treatment of Menstrual Migraine

By MacGregor E. Anne  

Drugs, Vol. 70, Iss. 14, 2010-10 ,pp. : 1799-1818

Adis International

Access to resources Recommend Favorite